Natixis’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Natixis's ABBV Position: Q3 2026 in Review
Natixis reduced its AbbVie (ABBV) stake by 3.1% in Q3 2026, selling an estimated $2.09M and leaving 258,897 shares worth $67.7M. The position accounts for 0.24% of the portfolio, ranked #50.
Natixis first reported a position in ABBV in Q2 2013 and has held it in 51 quarters since. The position peaked at $199M in Q3 2018. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Natixis held 258,897 shares of AbbVie worth $67.7M as of Q3 2026.
- Natixis sold 8,158 AbbVie shares in Q3 2026, an estimated $2.09M.
- AbbVie made up 0.24% of Natixis's portfolio in Q3 2026, its #50 holding.
- Natixis first reported a position in AbbVie in Q2 2013 and has held it in 51 quarters since.
- Natixis's AbbVie position peaked at $199M in Q3 2018.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Natixis's 13F filing for Q3 2026, filed 6 Nov 2026.